Latest Lipigon News & Updates

See the latest news and media coverage for Lipigon. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Lipigon

Biotech company developing blood lipid disorder treatments

lipigon.se
Headquarters
Umeå, Sweden
Founded year
2010
Company type
Public company
Number of employees
2–15

Last updated

Latest news about Lipigon

In short: Lipigon was delisted from Nasdaq First North in May 2026 after its lead candidate, Lipisense, failed to show efficacy in a Phase II clinical trial.

Company announcements

Lipigon

Lipigon's board proposes delisting from Nasdaq First North

The proposal is motivated by costs and strategic flexibility. CEO Johan Liwing terminates his agreement. AGM is held on May 18, 2026.

Unlock all announcements with a

Media coverage

Investing.com

Lipigon Pharmaceuticals AB (LPGO)

Lipigon Pharmaceuticals AB has a price-to-earnings (P/E) ratio of -0.070 (TTM). This compares to an industry average of 27.959. What is Lipigon Pharmaceuticals AB’s price-to-sales...

Life Science Sweden

Umeå company in turmoil after miss in study

A miscalculation in a clinical study has put Umeå-based Lipigon Pharmaceuticals under hard pressure. A strategic review of the company is ongoing, and the board does not rule out that...

Affärsvärlden

Emissionsguiden initiates coverage of Lipigon's rights issue

Lipigon Pharmaceuticals' board of directors has decided on a rights issue that needs to be voted through at an extraordinary general meeting on April 28. Lipigon Pharmaceuticals develops treatments against so...

Unlock all articles with a

Never miss news about Lipigon

Track Lipigon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Lipigon competitors & trending companies

Browse news for competitors to Lipigon and other trending companies.